Basson A, Weil C, Marx S, Dylla D, Collins M, Hadadi S
Adv Ther. 2025; 42(3):1522-1536.
PMID: 39912989
PMC: 11868148.
DOI: 10.1007/s12325-024-03102-6.
Baber A, Suganthan B, Ramasamy R
J Biol Eng. 2024; 18(1):48.
PMID: 39252065
PMC: 11385151.
DOI: 10.1186/s13036-024-00443-2.
Tok D
World J Clin Cases. 2024; 12(20):4301-4316.
PMID: 39015889
PMC: 11235547.
DOI: 10.12998/wjcc.v12.i20.4301.
Ivanov Y, Malsagova K, Goldaeva K, Pleshakova T, Kozlov A, Galiullin R
Micromachines (Basel). 2023; 14(10).
PMID: 37893383
PMC: 10609547.
DOI: 10.3390/mi14101946.
Sepulveda-Crespo D, Trevino-Nakoura A, Bellon J, Jimenez-Sousa M, Ryan P, Martinez I
J Clin Microbiol. 2022; 61(1):e0133122.
PMID: 36537787
PMC: 9879113.
DOI: 10.1128/jcm.01331-22.
Non-targeted hepatitis C virus screening in acute care healthcare settings in the Southern Appalachian region.
Chastain C, Jenkins C, Rose M, Moore D, Parker D, Cave B
J Am Coll Emerg Physicians Open. 2022; 3(5):e12819.
PMID: 36172306
PMC: 9467969.
DOI: 10.1002/emp2.12819.
A cross-sectional study of prolonged disengagement from clinic among people with HCV receiving care in a low-threshold, multidisciplinary clinic.
Kendall C, Fitzgerald M, Donelle J, Kwong J, Galanakis C, Boyd R
Can Liver J. 2022; 3(2):212-223.
PMID: 35991860
PMC: 9202788.
DOI: 10.3138/canlivj.2019-0020.
Laboratory-based dried blood spot testing for hepatitis C: A protocol for systematic review and meta-analysis of diagnostic accuracy.
Carty P, McCarthy M, ONeill S, Harrington P, ONeill M, Teljeur C
HRB Open Res. 2021; 3:78.
PMID: 34957372
PMC: 8666990.
DOI: 10.12688/hrbopenres.13166.1.
The Practicability of the Xpert HCV Viral Load Fingerstick Point-of-Care Assay in Primary Care Settings.
Petroff D, Batz O, Jedrysiak K, Kramer J, Berg T, Wiegand J
Viruses. 2021; 13(11).
PMID: 34835133
PMC: 8623012.
DOI: 10.3390/v13112327.
Optimizing diagnostic algorithms to advance Hepatitis C elimination in Italy: A cost effectiveness evaluation.
Marcellusi A, Mennini F, Ruf M, Galli C, Aghemo A, Brunetto M
Liver Int. 2021; 42(1):26-37.
PMID: 34582627
PMC: 9292516.
DOI: 10.1111/liv.15070.
Coordination, Cost, and Changing Epidemiology-Considerations in the Hepatitis C Care Cascade.
Yang N, Muir A
Hepatol Commun. 2021; 5(3):355-357.
PMID: 33681671
PMC: 7917277.
DOI: 10.1002/hep4.1667.
The performance of hepatitis C virus (HCV) antibody point-of-care tests on oral fluid or whole blood and dried blood spot testing for HCV serology and viral load among individuals at higher risk for HCV in South Africa.
Prabdial-Sing N, Gaelejwe L, Makhathini L, Thaver J, Manamela M, Malfeld S
Health Sci Rep. 2021; 4(1):e229.
PMID: 33614978
PMC: 7876859.
DOI: 10.1002/hsr2.229.
Disparities in Hepatitis C Linkage to Care in the Direct Acting Antiviral Era: Findings From a Referral Clinic With an Embedded Nurse Navigator Model.
Sherbuk J, McManus K, Kemp Knick T, Canan C, Flickinger T, Dillingham R
Front Public Health. 2019; 7:362.
PMID: 31828056
PMC: 6890553.
DOI: 10.3389/fpubh.2019.00362.
Streamlining the screening cascade for active Hepatitis C in Russia: A cost-effectiveness analysis.
Julicher P, Chulanov V, Pimenov N, Chirkova E, Yankina A, Galli C
PLoS One. 2019; 14(7):e0219687.
PMID: 31310636
PMC: 6634401.
DOI: 10.1371/journal.pone.0219687.
